In publication since 1904, JID is the premier global journal for original research on infectious diseases. JID is an official journal of @IDSAinfo
Joined February 2022
- Tweets3.5K
- Following8
- Followers10.8K
- Likes163
Experimental pneumococcal carriage reveals humoral correlates of susceptibility in virally suppressed adults with HIV
✅ Just Accepted
🔗 bit.ly/3UypObR
Rapid Differentiation of Vaccine and Wild-Type Measles Virus During an Ongoing Outbreak using a new molecular assay
✅ Just Accepted
🔗 bit.ly/4i3VgX0
Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions
✅ Just Accepted
🔗 bit.ly/4zDq5ck
Proteotyping reactivant toxoplasmic encephalitis reveals virulence-associated dense granule protein GRA5 polymorphisms
✅ Just Accepted
bit.ly/3Upxkpr
In-patient evolution can heterogeneously impact biofilm formation and intraosteoblastic behavior of Staphylococcus aureus in relapsing bone and joint infections
✅ Just Accepted
🔗 bit.ly/4s4EqvS
Inhaled Phosphatidylinositol 4-Kinase Beta (PI4KB) Inhibitor for the Treatment of Experimental Rhinovirus Infection in Patients with Asthma: A Phase 1b Randomized Controlled Study of GSK3923868
✅ Just Accepted
⭐ Editor's Choice
🔗 bit.ly/4hXwmIH
The Power of Storytelling in Science: Perspectives from Two Students and a Community Member
🔁 Repost
🔗 bit.ly/46InPV0
Long-term Outcomes in Previously Healthy non-HIV Individuals with Cryptococcal Meningitis Treated with Pulse-taper Corticosteroids for Post-infectious Inflammatory Syndrome
✅ Just Accepted
🔗 bit.ly/3W4eXqs
Reply to the comment “Galleria mellonella Models and Fluconazole for Candida auris: Caution on Extrapolating Preclinical Data to Clinical Practice”
✅ Just Accepted
🔗 bit.ly/4zu97xc
Galleria mellonella Models and Fluconazole for Candida auris: Caution on Extrapolating Preclinical Data to Clinical Practice
✅ Just Accepted
🔗 bit.ly/4dA1Ao1
Evaluation of gut microbiota composition in elite controllers and antiretroviral-treated people with HIV after aspirin versus atorvastatin administration
✅ Just Accepted
bit.ly/4jOsf4a
Translational and phase I evaluation of AZD0292, a novel, half-life extended anti-Pseudomonal Psl-PcrV bispecific monoclonal antibody
✅ Just Accepted
🔗 bit.ly/4ekWUm3
Chlamydia trachomatis (CT) antibody-mediated opsonophagocytosis is not associated with reduced endometrial or incident infection
✅ Just Accepted
🔗 bit.ly/4jfAfv0
Journal of Infectious Diseases retweeted
What happens when an antiviral works by causing mutations? In a new Let’s Talk ID episode, @JIDJournal Deputy Editor Jonathan Li, MD, FIDSA, talks molnupiravir and a recent paper that raised questions about its potential effects in mammalian cells.
Watch: bit.ly/471j3lt
Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus in People with HIV-1
✅ Just Accepted
bit.ly/3TNAras
Association of HPV16 E7-specific T cell responses in cervical lymphocytes and peripheral blood with regression of high-grade cervical intraepithelial neoplasia lesions
✅ Just Accepted
🔗 bit.ly/3Uhaosn
The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection
🔁 Repost
🔗 bit.ly/4yzUfgA
Journal of Infectious Diseases retweeted
On IDSA’s/@HIVMA’s Science Speaks: Learn about the efficacy of switching to doravirine/islatravir, how immunocompromised individuals hospitalized with COVID-19 remain at increased mortality risk & other research in @JIDJournal to inform clinical practice. bit.ly/4AYYFzi
Risk maps and spatial models for clinical infectious disease decision-making
🔁 Repost
✍️ @sethdjudson
🔗 bit.ly/4hxj8lD
Expert Consensus on Controlled Human Infection Studies for Gonorrhoea
🔁 Repost
🔗 bit.ly/4rzqz0e
